HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Claus Cursiefen Selected Research

Corneal Transplantation (Keratoplasty)

9/2022Outcomes of deep anterior lamellar keratoplasty and penetrating keratoplasty in keratoconic eyes with and without previous hydrops.
3/2022Influence of Body Position on Intraocular Pressure After Descemet Membrane Endothelial Keratoplasty: A Prospective Randomized Trial.
1/2022Impact of Early Intraocular Pressure Elevation on Postoperative Outcomes After Descemet Membrane Endothelial Keratoplasty in Non-glaucoma Patients.
1/2022Three-year follow-up of high-risk keratoplasty following fine-needle diathermy of corneal neovascularization combined with bevacizumab.
1/2022One threat, different answers: the impact of COVID-19 pandemic on cornea donation and donor selection across Europe.
1/2022Long-Term Outcome of Descemet Membrane Endothelial Keratoplasty in Eyes With Fuchs Endothelial Corneal Dystrophy Versus Pseudophakic Bullous Keratopathy.
12/2021Comparison of Mini-DMEK versus predescemetal sutures as treatment of acute hydrops in keratoconus.
12/2021Cutting Edge: Novel Treatment Options Targeting Corneal Neovascularization to Improve High-Risk Corneal Graft Survival.
10/2021Outcomes of Pseudophakic, Phakic, and Triple DMEK.
10/2021[Efficient Use of Corneal Grafts through Multimodal Donor Tissue Splitting].
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Claus Cursiefen Research Topics

Disease

40Corneal Neovascularization
01/2022 - 10/2002
17Fuchs' Endothelial Dystrophy
03/2022 - 12/2007
16Inflammation (Inflammations)
01/2021 - 04/2004
15Cataract (Cataracts)
10/2021 - 07/2012
14Glaucoma
10/2022 - 08/2013
14Neoplasms (Cancer)
01/2022 - 04/2004
11Neoplasm Metastasis (Metastasis)
09/2015 - 04/2004
10Keratoconus
12/2021 - 02/2006
7Macular Degeneration (Age-Related Maculopathy)
01/2022 - 12/2007
7Dry Eye Syndromes (Dry Eye Syndrome)
05/2021 - 12/2012
7Macular Edema
07/2020 - 03/2016
6Melanoma (Melanoma, Malignant)
01/2022 - 05/2009
6Wounds and Injuries (Trauma)
10/2020 - 07/2002
6Corneal Diseases (Corneal Disease)
01/2019 - 10/2009
6Keratitis
11/2017 - 07/2002
5Infections
06/2021 - 12/2007
5Hereditary Corneal Dystrophies
06/2018 - 12/2007
4Edema (Dropsy)
09/2022 - 08/2019
4Corneal Edema
03/2021 - 01/2017
4Hypersensitivity (Allergy)
05/2017 - 08/2004
3Retinal Detachment (Retinal Detachments)
05/2022 - 09/2017
3COVID-19
01/2022 - 07/2020
3Eye Diseases (Eye Disease)
01/2022 - 05/2015
3Diabetic Retinopathy (Retinopathy, Diabetic)
01/2019 - 04/2014
3Uveitis
05/2018 - 04/2014
3Corneal Injuries
03/2018 - 03/2013
2Astigmatism
09/2022 - 01/2014
2Limbal Stem Cell Deficiency
01/2021 - 02/2008
2Pain (Aches)
12/2020 - 10/2019
2Blister (Bulla)
12/2020 - 01/2019
2Ocular Hypertension (Glaucoma, Suspect)
02/2019 - 12/2016
2Chemical Burns (Chemical Burn)
01/2019 - 02/2008
2Retinal Diseases
05/2018 - 04/2014
2Corneal Opacity
03/2018 - 01/2015
2Atopic Dermatitis (Atopic Eczema)
05/2017 - 04/2009
2Disease Progression
01/2017 - 12/2014
2Nevus (Nevi)
04/2014 - 05/2002
2Blindness (Hysterical Blindness)
05/2013 - 10/2005
1Cysts
12/2022
1Carcinogenesis
02/2022
1Retinal Artery Occlusion
05/2021

Drug/Important Bio-Agent (IBA)

14Ophthalmic Solutions (Eye Drops)IBA
01/2017 - 12/2007
9Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2022 - 05/2009
9Bevacizumab (Avastin)FDA Link
01/2022 - 06/2007
5Proteins (Proteins, Gene)FDA Link
01/2022 - 10/2005
5CollagenIBA
01/2022 - 01/2011
5Retinaldehyde (Retinal)IBA
05/2021 - 04/2014
5GS 101IBA
09/2014 - 09/2009
4Biomarkers (Surrogate Marker)IBA
03/2021 - 05/2014
4SteroidsIBA
05/2019 - 03/2016
4Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
09/2017 - 10/2005
4CytokinesIBA
09/2017 - 01/2014
3Hyaluronan ReceptorsIBA
12/2020 - 07/2002
3AntigensIBA
05/2019 - 08/2004
32,4- diamino- 5- cyclohexyl- 6- methylpyrimidineIBA
05/2018 - 12/2016
3Vascular Endothelial Growth Factor CIBA
01/2016 - 04/2004
3Thrombospondin 1IBA
09/2015 - 04/2004
3Antisense OligonucleotidesIBA
09/2014 - 09/2009
2Sulfur HexafluorideIBA
01/2022 - 01/2019
2Complement System Proteins (Complement)IBA
05/2021 - 03/2021
2Dexamethasone (Maxidex)FDA LinkGeneric
05/2019 - 04/2014
2Clostridium sordellii lethal toxin LTIBA
02/2019 - 12/2016
2Monophenol Monooxygenase (Tyrosinase)IBA
01/2019 - 09/2015
2Riboflavin (Vitamin B2)FDA LinkGeneric
12/2018 - 03/2009
2Transforming Growth Factor beta (TGF-beta)IBA
09/2017 - 02/2016
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
09/2017 - 08/2002
2Vascular Endothelial Growth Factor Receptor-3 (Flt 4)IBA
01/2017 - 08/2004
2N-formyl-13-dihydrocarminomycin (NFD)IBA
09/2015 - 12/2014
2Cyclosporine (Ciclosporin)FDA LinkGeneric
09/2014 - 03/2012
2Insulin Receptor Substrate ProteinsIBA
09/2014 - 09/2009
2Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
04/2014 - 07/2006
2Ranibizumab (Lucentis)FDA Link
03/2014 - 03/2012
2OptisolIBA
09/2013 - 07/2012
2Melanins (Melanin)IBA
05/2009 - 05/2002
1Mitomycin (Mitomycin-C)FDA LinkGeneric
10/2022
1Pyrimidine DimersIBA
02/2022
1Immune Checkpoint InhibitorsIBA
01/2022
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2022
1RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
06/2021

Therapy/Procedure

59Corneal Transplantation (Keratoplasty)
09/2022 - 10/2002
21Sutures (Suture)
12/2021 - 04/2004
17Therapeutics
01/2022 - 08/2002
9Penetrating Keratoplasty
09/2022 - 02/2006
8Trabeculectomy (Trabeculoplasty)
10/2022 - 09/2013
5Lasers (Laser)
05/2022 - 04/2007
5Slit Lamp
02/2021 - 04/2014
4Phacoemulsification
05/2018 - 07/2012
3Diathermy
01/2022 - 08/2012
3Transplantation
09/2014 - 09/2009
2Ambulatory Surgical Procedures (Outpatient Surgery)
10/2019 - 02/2011
2Excimer Lasers
03/2018 - 10/2002
2Trephining
06/2012 - 10/2002
2Organ Transplantation
01/2011 - 07/2010
2Off-Label Use
10/2009 - 01/2008
2Drug Therapy (Chemotherapy)
06/2008 - 01/2003
1Contact Lenses
12/2022
1Patient Positioning
03/2022
1Endotamponade
01/2022
1Donor Selection
01/2022
1Cell- and Tissue-Based Therapy (Cell Therapy)
10/2021